Boots Sore Throat Relief Dual Action 2.4mg lozenges blackcurrant

国家: 英国

语言: 英文

来源: MHRA (Medicines & Healthcare Products Regulatory Agency)

有效成分:

Hexylresorcinol

可用日期:

The Boots Company Plc

ATC代码:

R02AA12

INN（国际名称）:

Hexylresorcinol

剂量:

2.4mg

药物剂型:

Lozenge

给药途径:

Oromucosal

类:

No Controlled Drug Status

处方类型:

Valid as a prescribable product

產品總結:

BNF: 12030300

资料单张

1
2
3
PLACEHOLDER
Read all of this leaflet carefully before you
start taking this medicine because
it contains important information for you.
• Always take this medicine exactly
as described in this leaflet.
• Keep this leaflet. You may need to read
it again.
• Ask your pharmacist if you need more
information or advice.
• If you get any side effects, talk to your
doctor or pharmacist. This includes any
possible side effects not listed in this
leaflet (see section 4).
• You must contact a doctor if your
symptoms worsen or do not improve.
What is in this leaflet
1.
What this medicine is and what it is
used for
2. What you need to know before you take
this medicine
3. How to take this medicine
4. Possible side effects
5. How to store this medicine
6.
Contents of the pack and other information
What this medicine is and
what it is used for
These lozenges are recommended for the relief
of sore throats and associated pain. The active
ingredient Hexylresorcinol is an antiseptic
which combats the bacteria that cause sore
throats. It also acts as a local anaesthetic to
bring soothing relief from pain and discomfort.
What you need to know before you
take this medicine
Do not
• take these lozenges if you are hypersensitive
(allergic) to the active ingredient or any of
the other ingredients in this medicine (listed
in section 6).
• give to children under 6 years.
Pregnancy and breast-feeding
Ask your doctor or pharmacist for advice
before taking any medication.
If you are pregnant, or think you may be
pregnant please ask your doctor or pharmacist
before using these lozenges.
They may not be suitable for you.
Important information about some
of the ingredients of this medicine
• Each lozenge contains a total of 2.4g of
sucrose and glucose. This should be taken
into account if you have diabetes mellitus.
If you have been told by your doctor that you
have an intolerance to some sugars, contact
your doctor before taking this product.
• The colours ponceau 4R (E124) and brilliant
black (E151) in this medicine may

产品特点

1.
NAME OF THE MEDICINAL PRODUCT
Lloydspharmacy Double Action Throat Lozenges Blackcurrant
Superdrug Blackcurrant Sore Throat Dual Action Lozenges
Morrisons Dual Action Antiseptic Throat Lozenges Blackcurrant Flavour.
Boots Sore Throat Relief Double Action 2.4 mg Lozenges Blackcurrant
Flavour
Mac Dual Action Blackcurrant Flavour
Asda Dual Action Blackcurrant Flavour 2.4 mg Throat Lozenges
Mac Dual Action Blackcurrant Flavour 2.4mg Lozenges
Optipharma Dual Action Blackcurrant Flavour 2.4mg Lozenges
Well Pharmaceuticals Double Action Sore Throat Relief 2.4 mg Lozenges
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Hexylresorcinol B.P. 2.4mg per lozenge
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Lozenge
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
As an antiseptic and local anaesthetic for the relief of sore throat
and its associated
pain.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
Adults, the Elderly, and Children aged 6 years and over:- One lozenge
dissolved
slowly in the mouth every three hours or as required. Do not take more
than 12
lozenges in 24 hours.
Not to be given to children under 6 years.
Method of administration
Oral
4.3
CONTRAINDICATIONS
Hypersensitivity to the active substance or to any of the excipients
listed in section
6.1.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Not to be given to children under 6 years.
Contains a total of 2.4g of sucrose and liquid glucose solids per
lozenge.
Patients with rare hereditary problems of fructose intolerance,
glucose-
galactose malabsorption or
sucrase-isomaltase insufficiency should not take
this medicine.
4.5
INTERACTIONS WITH OTHER MEDICAMENTS AND OTHER FORMS OF INTERACTION
None known.
4.6
FERTILITY, PREGNANCY AND LACTATION
Pregnancy
There is no or inadequate evidence of the safety of the active
ingredients in this
medicine in human pregnancy. The potential risk for humans is unknown.
In the absence of sufficient data, the use during pregnancy is not
recommended.
Breast-feeding
It is not known whether the active ingre